Skip Navigation



Radiation Protection Dosimetry Advance Access published online on January 28, 2008

Radiation Protection Dosimetry, doi:10.1093/rpd/ncm474
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
127/1-4/548    most recent
ncm474v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Fritsch, P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Fritsch, P.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© The Author 2007. Published by Oxford University Press. All rights reserved. For Permissions, please email: journals.permissions@oxfordjournals.org

UNCERTAINTIES IN COMMITTED EQUIVALENT DOSES TO THE THYROID AFTER INGESTION OR INHALATION OF DIFFERENT CHEMICAL FORMS OF 125-129-131I

P. Fritsch*

Laboratoire de Radiotoxicologie, SRCA/DRR/DSV/CEA, BP 12, 91680 Bruyères le Châtel, France

* Corresponding author: paul.fritsch{at}cea.fr

The aim of this study is to reanalyse uncertainties in committed equivalent doses to the thyroid after ingestion of 125-129-131I using the last variability reported for anatomical and physiological parameters of the different ICRP age groups, and to estimate uncertainties after inhalation exposure to different chemical forms of iodine (elemental and organic iodine vapours, iodine loaded particles (study limited to workers for activity median aerodynamic diameters of 1 and 5 µm)). The 95% confidence interval appears in the range of 7–18 (ratio of 97.5 versus 2.5 percentile values of the log-normal distribution: GSD4). The largest uncertainties are observed for 129I which is due to its long half-life. Because of the small range of beta rays of 125-129I when compared with that of 131I, and the preferential location of iodine within the colloid of the thyroid follicles, the use of calculated doses for a realistic risk assessment is discussed.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?




Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.